| scholarly article | Q13442814 |
| P50 | author | Marianne C. Verhaar | Q40340965 |
| Imo Hoefer | Q57312262 | ||
| Ronald H. W. M. Derksen | Q73744763 | ||
| P2093 | author name string | Hein A Koomans | |
| Imo E Hoefer | |||
| Peter E Westerweel | |||
| Remco K M A C Luijten | |||
| P2860 | cites work | Clearance of Apoptotic Cells in Human SLE | Q22306425 |
| Circulating endothelial progenitor cells and cardiovascular outcomes | Q28271167 | ||
| Isolation of putative progenitor endothelial cells for angiogenesis | Q28302884 | ||
| The 1982 revised criteria for the classification of systemic lupus erythematosus | Q29547225 | ||
| Relevance of monocytic features for neovascularization capacity of circulating endothelial progenitor cells | Q33194273 | ||
| Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus | Q34098573 | ||
| Endothelial progenitor cells: characterization and role in vascular biology | Q35867837 | ||
| Surviving the butterfly and the wolf: mortality trends in systemic lupus erythematosus | Q35879759 | ||
| Atherosclerosis in patients with autoimmune disorders | Q36173656 | ||
| Effect of prednisone and hydroxychloroquine on coronary artery disease risk factors in systemic lupus erythematosus: a longitudinal data analysis | Q36747001 | ||
| Circulating endothelial progenitor cells, vascular function, and cardiovascular risk | Q39513285 | ||
| Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: proof of concept for the clinical importance of endogenous vascular repair | Q40417766 | ||
| Increased apoptotic peripheral blood neutrophils in systemic lupus erythematosus: relations with disease activity, antibodies to double stranded DNA, and neutropenia | Q42025177 | ||
| Increased apoptosis of bone marrow CD34(+) cells and impaired function of bone marrow stromal cells in patients with systemic lupus erythematosus | Q43808480 | ||
| Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. | Q44441787 | ||
| Systemic lupus erythematosus: an independent risk factor for endothelial dysfunction in women | Q44774810 | ||
| Lymphocyte apoptosis and macrophage function: correlation with disease activity in systemic lupus erythematosus | Q46428350 | ||
| Abnormal mechanical properties of larger arteries in postmenopausal women with systemic lupus erythematosus | Q48956031 | ||
| Soluble factors released by endothelial progenitor cells promote migration of endothelial cells and cardiac resident progenitor cells. | Q51345347 | ||
| Endothelial cell apoptosis in systemic lupus erythematosus: a common pathway for abnormal vascular function and thrombosis propensity. | Q52094951 | ||
| Endothelial Progenitor Cell Dysfunction: A Novel Concept in the Pathogenesis of Vascular Complications of Type 1 Diabetes | Q57790499 | ||
| Endothelial Progenitor Cells: Mainly Derived From the Monocyte/Macrophage–Containing CD34 − Mononuclear Cell Population and Only in Part From the Hematopoietic Stem Cell–Containing CD34 + Mononuclear Cell Population | Q57790546 | ||
| Suppression of haematopoiesis by IgG autoantibodies from patients with systemic lupus erythematosus (SLE) | Q71696143 | ||
| Accelerated in vitro apoptosis of lymphocytes from patients with systemic lupus erythematosus | Q72332814 | ||
| Lupus anticoagulant autoantibody induces apoptosis in umbilical vein endothelial cells: involvement of annexin V | Q72362929 | ||
| Peripheral blood "endothelial progenitor cells" are derived from monocyte/macrophages and secrete angiogenic growth factors | Q73075799 | ||
| Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study | Q73106702 | ||
| Apoptosis of CD34+ cells after incubation with sera of leukopenic patients with systemic lupus erythematosus | Q73694068 | ||
| Bone marrow progenitor cell reserve and function and stromal cell function are defective in rheumatoid arthritis: evidence for a tumor necrosis factor alpha-mediated effect | Q77678283 | ||
| Lymphocyte apoptosis in systemic lupus erythematosus: relationships with Fas expression, serum soluble Fas and disease activity | Q78248072 | ||
| Impaired brachial artery endothelium dependent flow mediated dilation in systemic lupus erythematosus: preliminary observations | Q80816858 | ||
| Increased total number but impaired migratory activity and adhesion of endothelial progenitor cells in patients on long-term hemodialysis | Q80880878 | ||
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | systemic lupus erythematosus | Q1485 |
| endothelium | Q111140 | ||
| P304 | page(s) | 865-870 | |
| P577 | publication date | 2007-02-28 | |
| P1433 | published in | Annals of the Rheumatic Diseases | Q4767876 |
| P1476 | title | Haematopoietic and endothelial progenitor cells are deficient in quiescent systemic lupus erythematosus | |
| P478 | volume | 66 |
| Q34089816 | A distinct subset of proinflammatory neutrophils isolated from patients with systemic lupus erythematosus induces vascular damage and synthesizes type I IFNs |
| Q34240254 | Activation of type I interferon pathway in systemic lupus erythematosus: association with distinct clinical phenotypes |
| Q92462247 | Biomarkers of subclinical atherosclerosis in patients with psoriatic arthritis |
| Q34576771 | Bone marrow alterations and lower endothelial progenitor cell numbers in critical limb ischemia patients |
| Q27016554 | Cardiovascular disease in lupus: insights and updates |
| Q45738754 | Circulating endothelial cells and angiogenic proteins in patients with systemic lupus erythematosus |
| Q83233981 | Circulating endothelial progenitor cells are reduced in SLE in the absence of coronary artery calcification |
| Q84763358 | Comparative study on circulating endothelial progenitor cells in systemic lupus erythematosus patients at active stage |
| Q38114011 | Concise review: endothelial stem and progenitor cells and their habitats |
| Q51182420 | Decreased circulating endothelial progenitor cells as an early risk factor of subclinical atherosclerosis in systemic lupus erythematosus. |
| Q41656076 | Differential expression of the transcription factor ARID3a in lupus patient hematopoietic progenitor cells |
| Q51114187 | Endothelial Progenitor Cells as a Marker of Endothelial Dysfunction and Atherosclerosis in Ankylosing Spondylitis: A Cross-Sectional Study. |
| Q90455731 | Endothelial Progenitor Cells: New Targets for Therapeutics for Inflammatory Conditions With High Cardiovascular Risk |
| Q37478067 | Endothelial progenitor cell dysfunction in rheumatic disease |
| Q88906103 | Endothelial progenitor cells and rheumatic disease modifying therapy |
| Q35774189 | Endothelial progenitor cells in cardiovascular disease and chronic inflammation: from biomarker to therapeutic agent |
| Q37066764 | Endothelial progenitor cells in neovascularization of infarcted myocardium |
| Q36084953 | Endothelial progenitor cells: a new player in lupus? |
| Q37624581 | Endothelial progenitor cells: novel players in the pathogenesis of rheumatic diseases |
| Q41936412 | Enhanced adhesive properties of endothelial progenitor cells (EPCs) in patients with SLE. |
| Q42756303 | High Levels of Circulating Endothelial Progenitor Cells Are Associated with Acrotism in Patients with Takayasu Arteritis |
| Q92312835 | High levels of endothelial progenitor cells and circulating endothelial cells in patients with Behçet's disease and their relationship to disease activity |
| Q42703913 | How does interferon-α insult the vasculature? Let me count the ways |
| Q36059617 | Interferon-alpha promotes abnormal vasculogenesis in lupus: a potential pathway for premature atherosclerosis |
| Q35152132 | Lupus-prone New Zealand Black/New Zealand White F1 mice display endothelial dysfunction and abnormal phenotype and function of endothelial progenitor cells |
| Q47140121 | MeCP2 mediated dysfunction in senescent EPCs |
| Q34343906 | Mechanisms of premature atherosclerosis in rheumatoid arthritis and lupus |
| Q38328472 | Mesenchymal stem cells transplantation for systemic lupus erythematosus |
| Q50985903 | Metabolic syndrome is associated with decreased circulating endothelial progenitor cells and increased arterial stiffness in systemic lupus erythematosus. |
| Q90283507 | New Frontiers: ARID3a in SLE |
| Q81786177 | Normal levels and function of endothelial progenitor cells in patients with psoriatic arthritis |
| Q44937839 | Osteoprotegerin causes apoptosis of endothelial progenitor cells by induction of oxidative stress |
| Q33387473 | Predictors of the first cardiovascular event in patients with systemic lupus erythematosus - a prospective cohort study |
| Q37573524 | Premature vascular damage in systemic lupus erythematosus |
| Q37549027 | Premature vascular damage in systemic lupus erythematosus: an imbalance of damage and repair? |
| Q36392411 | Reduced number and impaired function of circulating progenitor cells in patients with systemic lupus erythematosus |
| Q37295488 | Role of guanylate binding protein-1 in vascular defects associated with chronic inflammatory diseases. |
| Q28649846 | The endothelial deprotection hypothesis for lupus pathogenesis: the dual role of C1q as a mediator of clearance and regulator of endothelial permeability |
| Q35169351 | The interplay of inflammation and cardiovascular disease in systemic lupus erythematosus |
Search more.